High‐fidelity CRISPR/Cas12a dual‐crRNA screening reveals novel synergistic interactions in hepatocellular carcinoma
Authors:
Open Access
- 28 July 2024
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 14 (7) , e1758
Abstract
: CRISPR/Cas12a‐based combinational screening has shown remarkable potential for identifying genetic interactions. Here, we describe an innovative method for combinational genetic screening with rapid construction of a dual‐CRISPR RNA (crRNA) library using gene splicing through overlap extension PCR (SOE PCR) and the adoption of CeCas12a, which we previously identified with strict PAM recognition and low off‐targeting to guarantee fidelity and efficiency. The custom‐pooled SOE crRNA array (SOCA) library for double‐knockout screening could be conveniently constructed in the laboratory for widespread use, and the CeCas12a‐mediated high‐fidelity screen displayed good performance even under a negative selection screen. By designing a SOCA dual‐crRNA library that covered most of the kinase and metabolism‐associated gene targets of FDA‐approved drugs implicated in hepatocellular carcinoma (HCC) tumourigenesis, novel cross‐talk between the two gene sets was negatively selected to inhibit HCC cell growth in vitro and in vivo and was validated using virtual double‐knockdown screening based on TCGA databases. Thus, this rapid, efficient and high‐fidelity double‐knockout screening system is promising for systemically identifying potential genetic interactions between multiple gene sets or combinations of FDA‐ approved drugs for clinical translational medicine in the future.Keywords
Funding Information
- National Natural Science Foundation of China (32171210, 32101196, 32371271)
- China Postdoctoral Science Foundation (2021TQ0253, 2022M712468)
- Fundamental Research Funds for the Central Universities (2042022kf1189)
- National Key Research and Development Program of China (2022YFA1303500)
This publication has 36 references indexed in Scilit:
- In vivo high-throughput profiling of CRISPR–Cpf1 activityNature Methods, 2016
- Multiplex gene editing by CRISPR–Cpf1 using a single crRNA arrayNature Biotechnology, 2016
- Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEMProceedings of the National Academy of Sciences, 2016
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas SystemCell, 2015
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleasesNature Biotechnology, 2014
- Targeting RAS–ERK signalling in cancer: promises and challengesNature Reviews Drug Discovery, 2014
- Building high-resolution synthetic lethal networks: a ‘Google map’ of the cancer cellTrends in Molecular Medicine, 2014
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human CellsScience, 2014
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular CarcinomaGastroenterology, 2011
- Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinomaHepatology, 2007